Evidence map›Paper›PMID 23878801›Full record

ArticleBioMed research international2013

Protein coexpression using FMDV 2A: effect of "linker" residues.

Ekaterina Minskaia, Martin D Ryan

Abstract read
In one paragraph

Article in BioMed research international, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

40 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Targeted knock-in ofMolecular therapy. Nucleic acids · 2024
    Article
  9. Ribosomal control in RNA virus-infected cells.Frontiers in microbiology · 2022
    Review
  10. Article
  11. Article
  12. Synthetic polycistronic sequences in eukaryotes.Synthetic and systems biotechnology · 2021
    Review
  13. Review
  14. Article
  15. Efficient photoactivatable Dre recombinase for cell type-specific spatiotemporal control of genome engineering in the mouse.Proceedings of the National Academy of Sciences of the United States of America · 2020
    Article
  16. Article
  17. Article
  18. Article
  19. MultiplexedContrast media & molecular imaging · 2020
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Ekaterina MinskaiaBiomedical Sciences Research Complex, North Haugh, University of St. Andrews, St. Andrews, Fife KY16 9ST, UK. minskayakat@hotmail.com
Martin D Ryan

Funding

Biotechnology and Biological Sciences Research Council BB/E010709/1Biotechnology and Biological Sciences Research Council BB/H007849/1Biotechnology and Biological Sciences Research Council C20035Medical Research Council G0901002
6 · The paper itself

Abstract

Many biomedical applications absolutely require, or are substantially enhanced by, coexpression of multiple proteins from a single vector. Foot-and-mouth disease virus 2A (F2A) and "2A-like" sequences (e.g., Thosea asigna virus 2A; T2A) are used widely for this purpose since multiple proteins can be coexpressed by linking open reading frames (ORFs) to form a single cistron. The activity of F2A "cleavage" may, however, be compromised by both the use of shorter versions of F2A and the sequences (derived from multiple-purpose cloning sites) used to link F2A to the upstream protein. To characterise these effects, different lengths of F2A and T2A were inserted between green and cherry fluorescent proteins. Mutations were introduced in the linker region immediately upstream of both F2A- and T2A-based constructs and activities determined using both cell-free translation systems and transfected cells. In shorter versions of F2A, activity may be affected by both the C-terminal sequence of the protein upstream and, equally strikingly, the residues immediately upstream introduced during cloning. Mutations significantly improved activity for shorter versions of F2A but could decrease activity in the case of T2A. These data will aid the design of cloning strategies for the co-expression of multiple proteins in biomedical/biotechnological applications.

Indexed as

Amino Acid SequenceBase SequenceCloning, MolecularDNA Transposable ElementsGenetic VectorsMolecular Sequence DataRecombinant ProteinsViral ProteinsDNA Transposable ElementsRecombinant ProteinsViral Proteinsvirus protein 2A

Identifiers

PMID23878801
PMCPMC3710640

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.